Nexo Therapeutics
Gesine Veits is a Medicinal Chemist at nexo therapeutics. Previously worked as a Senior Scientist at Treeline Biosciences and held various research positions at C4 Therapeutics, Inc. Also worked as a Postdoctoral Researcher at the University of Michigan, Graduate Student Researcher at UC Santa Barbara, Visiting Researcher at LMU, and Undergraduate Student Researcher at Tulane University. Holds a Ph.D. in Organic Chemistry from UC Santa Barbara and a B.S. in Chemistry from Tulane University. Specializes in developing low molecular weight gelators for sensing heavy metals.
Nexo Therapeutics
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.